Skip to content
Screener

Revvity RVTY Q4 2025 Annual earnings

Reported February 2, 2026 · Before market open

Revenue$772.1MBeat by $7.1M
EPS$1.70Beat by $0.13
Revenue estimate$764.9M
EPS estimate$1.57

Next report

Oct 26, 2026 (in 2 months)
Revenue estimate$694.1M
EPS estimate$1.28

Financials

Q4 2025

Income statement

See full
Revenue$772.1M+5.9%
Operating income$111.7M-5.9%
Net income$98.4M+3.9%
EPS (diluted)$0.86+10.3%

Balance sheet

See full
Cash & equivalents$921.0M-20.9%
Total debt$3.4B+2.2%
Total equity$7.3B-5.4%
Total assets$12.2B-1.8%

Cash flow

See full
Operating cash flow$182.0M+4.4%
CapEx$20.2M-17.5%
Free cash flow$161.8M+8.0%

Valuation & ratios

Valuation

as of 12/28/25
See full
Market cap$10.97B-19.2%
Enterprise value$13.45B-14.6%
P/E45.5×-4.8×
P/S3.8×-1.1×

Profitability

See full
Operating margin12.5%-0.1pp
Net margin8.4%-1.4pp
FCF margin17.8%-1.8pp

Returns & leverage

See full
Return on equity3.2%-0.2pp
Debt / equity0.5×0.0×
Current ratio1.7×-1.9×

Segments

By segment

See full
Diagnostics$390.1M+10.0%
Life Sciences$382.0M+1.9%

By product

See full
Service$125.1M+14.6%

FAQ

When did Revvity report Q4 2025 earnings?
Revvity (RVTY) reported Q4 2025 earnings on February 2, 2026 before market open.
What were Revvity's Q4 2025 revenue and EPS?
Revvity reported revenue of $772.1M and eps of $1.70 for Q4 2025.
Did Revvity beat estimates in Q4 2025?
Revenue beat the consensus estimate of $764.9M by $7.1M. EPS beat the consensus estimate of $1.57 by $0.13.
How did Revvity's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.9% from $729.4M a year earlier and eps grew 19.7% from $1.42.
Where can I find Revvity's Q4 2025 SEC filings?
You can read the 8-K earnings release (0000031791-26-000007) and the 10-K periodic report (0000031791-26-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.